FDA Inspection 857625 — Glaxo Wellcome S.A.
The FDA completed an inspection of Glaxo Wellcome S.A. on Sep 27, 2013 in Aranda De Duero. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions or practices were found, but the agency is not prepared to take or recommend any administrative or regulatory action). Product area: Drugs.
Inspection Details
- Classification
- Voluntary Action Indicated (VAI)
- End Date
- Sep 27, 2013
- Fiscal Year
- 2013
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Aranda De Duero (Spain)